Your browser doesn't support javascript.
loading
Optimized SEEG-guided three-dimensional radiofrequency thermocoagulation for insular epilepsy.
Dai, Yang; Zhang, Huaqiang; Fan, Xiaotong; Wei, Penghu; Shan, Yongzhi; Zhao, Guoguang.
  • Dai Y; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun St., Xicheng District, Beijing, 100053, China.
  • Zhang H; Clinical Research Center for Epilepsy, Capital Medical University, Beijing, 100053, China.
  • Fan X; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun St., Xicheng District, Beijing, 100053, China.
  • Wei P; Clinical Research Center for Epilepsy, Capital Medical University, Beijing, 100053, China.
  • Shan Y; Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun St., Xicheng District, Beijing, 100053, China.
  • Zhao G; Clinical Research Center for Epilepsy, Capital Medical University, Beijing, 100053, China.
Acta Neurochir (Wien) ; 165(1): 249-258, 2023 01.
Article en En | MEDLINE | ID: mdl-36342542
PURPOSE: The high risk of resection surgery for drug-resistant insular epilepsy has driven interest in new treatment techniques. Stereo-electroencephalography-guided three-dimensional radiofrequency thermocoagulation (SEEG-3D RFTC) offers an alternative option. Herein, we present the detailed protocol and investigation of the efficacy and safety of a preliminary observational study. METHODS: From February 2017 to April 2021, ten patients diagnosed with insular epilepsy were enrolled in the study. They underwent implantation of a combination of SEEG electrodes to form a high-density focal stereo-array in insula, including oblique electrodes through the long axis of insula and orthogonal electrodes to widely cover the medial and lateral insula. SEEG-3D RFTC was performed between two contiguous contacts of the same electrode, or between two adjacent contacts of different electrodes. RESULTS: Surgical procedures were well tolerated, with no related long-term complications. Seizure-free outcome was achieved in seven patients (70%), including ILAE I in four and ILAE II in three. Two other (20%) patients had rare seizures (ILAE III). One (10%) patient experienced an ILAE IV outcome (follow-up = 12--63 months). The responder rate (including ILAE I-IV) was 100%. CONCLUSION: The optimized SEEG-3D RFTC is an effective and safe option for the treatment of drug-resistant insular epilepsy.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Epilepsia Refractaria Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epilepsia / Epilepsia Refractaria Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article